A Randomized Trial of Peginterferon alpha-2a With or Without Ribavirin for HBeAg-Negative Chronic Hepatitis B


Rijckborst V., ter Borg M. J., Cakaloglu Y., Ferenci P., Tabak F., Akdogan M., ...Daha Fazla

AMERICAN JOURNAL OF GASTROENTEROLOGY, cilt.105, sa.8, ss.1762-1769, 2010 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 105 Sayı: 8
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1038/ajg.2010.186
  • Dergi Adı: AMERICAN JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1762-1769
  • İstanbul Üniversitesi Adresli: Evet

Özet

OBJECTIVES: Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients are at high risk of treatment relapse after any antiviral therapy. Combining peginterferon alpha-2a with ribavirin might improve sustained response rates.